ReviewHealth economics review2018

Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands.

Carin A Uyl-de Groot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.